<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">Timisoara_Med</journal-id>
      <journal-title-group>
        <journal-title>TIMISOARA MEDICAL JOURNAL</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Timisoara_Med</abbrev-journal-title>
        <abbrev-journal-title abbrev-type="pubmed">TIMISOARA MEDICAL JOURNAL</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">1583-526X</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.35995/tmj20200109</article-id>
      <article-id pub-id-type="publisher-id">Timisoara_Med-2020-9</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Increase in Percentage of Seronegative <italic>Toxoplasma gondii</italic> and Cytomegalovirus in Pregnant Women: An Improvement in Hygienic Conditions in Certain Areas?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Navolan</surname>
            <given-names>Dan-Bogdan</given-names>
          </name>
          <xref rid="af1-Timisoara_Med-2020-9" ref-type="aff">1</xref>
          <xref rid="c1-Timisoara_Med-2020-9" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gorun</surname>
            <given-names>Florin</given-names>
          </name>
          <xref rid="af1-Timisoara_Med-2020-9" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oancea</surname>
            <given-names>Cristian</given-names>
          </name>
          <xref rid="af2-Timisoara_Med-2020-9" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ciohat</surname>
            <given-names>Ioana-Mihaela</given-names>
          </name>
          <xref rid="af3-Timisoara_Med-2020-9" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mali&#x21B;a</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref rid="af4-Timisoara_Med-2020-9" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Craina</surname>
            <given-names>Marius Lucian</given-names>
          </name>
          <xref rid="af1-Timisoara_Med-2020-9" ref-type="aff">1</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-Timisoara_Med-2020-9"><label>1</label>Department of Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, 300041 Timi&#x219;oara, Romania; <email>florin.gorun@yahoo.com</email> (F.G.); <email>mariuscraina@hotmail.com</email> (M.L.C.)</aff>
      <aff id="af2-Timisoara_Med-2020-9"><label>2</label>Department of Infectious Diseases, Victor Babes University of Medicine and Pharmacy, 300041 Timi&#x219;oara, Romania; <email>oancea@umft.ro</email></aff>
      <aff id="af3-Timisoara_Med-2020-9"><label>3</label>Laboratory of Antenatal Medicine, City Emergency Hospital, 300041 Timi&#x219;oara, Romania; <email>tucaioana@yahoo.com</email></aff>
      <aff id="af4-Timisoara_Med-2020-9"><label>4</label>Department of Radiology, Victor Babes University of Medicine and Pharmacy, 300041 Timi&#x219;oara, Romania; <email>dmalita@gmail.com</email></aff>
      <author-notes>
        <corresp id="c1-Timisoara_Med-2020-9"><label>*</label>Correspondence: <email>navolan@yahoo.com</email>; Tel.: +40-722-960-911</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>11</month>
        <year>2020</year>
      </pub-date>
      <volume>2020</volume>
      <issue>1</issue>
      <elocation-id>9</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>09</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>10</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2020 Copyright by the authors.</copyright-statement>
        <copyright-year>2020</copyright-year>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>Licensed as an open access article using a CC BY 4.0 license.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>(1) Background: <italic>Toxoplasma gondii</italic> and cytomegalovirus belong to a group of pathogens entities called TORCH agents. TORCH represents an acronym which derives from the name of a series of certain pathogenic agents (<bold><italic>T</italic></bold><italic>oxoplasma gondii</italic>, <bold>O</bold>ther agents, <bold>R</bold>ubella virus, <bold>C</bold>ytomegalovirus, <bold>H</bold>erpes virus). They could cross the placenta barrier and cause serious damage to the fetus if a primary infection occurs in a pregnant woman. Immunized women are relatively protected against a reinfection and the risk of a materno-fetal infection in these categories of pregnant women is considered low. (2) Aim of the study: To analyze changes in the percentage of pregnant women seronegative to <italic>Toxoplasma gondii</italic> and cytomegalovirus along a period of ten years, from 2008 to 2018. (3) Material and Methods: We studied the changes in percentage of seronegative <italic>Toxoplasma gondii</italic> and Cytomegalovirus pregnant women along two periods: 2008&#x2013;2010 and 2015&#x2013;2018. Only pregnant women with declared medium of provenience and unequivocal results were enrolled in the study. (4) Results: In urban areas, we found an increase in the percentage of pregnant women seronegative to <italic>Toxoplasma gondii</italic> (RR = 1.488, <italic>p</italic> &lt; 0.0001), respectively to cytomegalovirus (RR = 1.985, <italic>p</italic> &lt; 0.0001), from 2008&#x2013;2010 to 2015&#x2013;2018. A similar increasing trend was found also in rural areas: <italic>Toxoplasma gondii</italic> (RR = 1.136, <italic>p</italic> &lt; 0.0322), respectively cytomegalovirus (RR = 1.088, <italic>p</italic> &lt; 0.8265) but it did not reach a significant threshold for cytomegalovirus. (5) Conclusion: Our study showed that the percentage of women seronegative to <italic>Toxoplasma gondii</italic> and cytomegalovirus antibodies increases along a period of ten years, from 2008&#x2013;2010 to 2015&#x2013;2018, in both urban and rural areas. Probably, the main cause of this trend is represented by the improvement in hygienic condition and food quality control. These results present an argument for continuing the TORCH screening of pregnant women.</p>
      </abstract>
      <kwd-group>
        <kwd><italic>Toxoplasma gondii</italic></kwd>
        <kwd>cytomegalovirus</kwd>
        <kwd>trend</kwd>
        <kwd>susceptibility</kwd>
        <kwd>pregnant women</kwd>
      </kwd-group>
	     <custom-meta-group>
        <custom-meta>
          <meta-name>How to cite</meta-name>
          <meta-value>Navolan, D.-B.; Gorun, F.; Oancea, C.; Ciohat, I.-M.; Mali&#x21B;a, D.; Craina, M.L. Increase of Percentage of Seronegative <italic>Toxoplasma gondi</italic> and Cytomegalovirus in Pregnant Women: An Improvement of Hygienic Conditions in Certain Areas?. <italic>Timisoara Med.</italic> <bold>2020</bold>, <italic>2020</italic>(1), 9; doi:10.35995/tmj20200109.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p><italic>Toxoplasma gondii</italic> and cytomegalovirus belong to a group of pathogens entities called TORCH agents. TORCH represents an acronym which derives from the name of a series of certain pathogenic agents (<bold><italic>T</italic></bold><italic>oxoplasma gondii</italic>, <bold>O</bold>ther agents, <bold>R</bold>ubella virus, <bold>C</bold>ytomegalovirus, <bold>H</bold>erpes virus). They could cross the placenta barrier and cause serious damage to the fetus if a primary infection occurs during a woman&#x2019;s pregnancy [<xref ref-type="bibr" rid="B1-Timisoara_Med-2020-9">1</xref>]. Immunized women are relatively protected against a reinfection and the risk of a materno-fetal infection in these categories of pregnant women is considered to be low [<xref ref-type="bibr" rid="B2-Timisoara_Med-2020-9">2</xref>,<xref ref-type="bibr" rid="B3-Timisoara_Med-2020-9">3</xref>]. In particular cases, certain IgG seropositive women could be reinfected if they contact other strains of the same pathogenous agents or when the immune system is weakened by an immunosuppressive therapy or disease [<xref ref-type="bibr" rid="B4-Timisoara_Med-2020-9">4</xref>,<xref ref-type="bibr" rid="B5-Timisoara_Med-2020-9">5</xref>]. Most immunized women have a sufficiently high IgG antibodies titer to neutralize agents before they cross the placenta and to prevent infection and damage in the fetus [<xref ref-type="bibr" rid="B2-Timisoara_Med-2020-9">2</xref>,<xref ref-type="bibr" rid="B3-Timisoara_Med-2020-9">3</xref>].</p>
      <p><italic>Toxoplasma gondii</italic> is an intracellular parasite and an important cause of congenital malformations in many countries [<xref ref-type="bibr" rid="B6-Timisoara_Med-2020-9">6</xref>]. The main hosts where the reproduction of <italic>Toxoplasma gondii</italic> takes place are domestic and wild cats [<xref ref-type="bibr" rid="B7-Timisoara_Med-2020-9">7</xref>], but other species could be infected and carry oocysts, as well [<xref ref-type="bibr" rid="B8-Timisoara_Med-2020-9">8</xref>,<xref ref-type="bibr" rid="B9-Timisoara_Med-2020-9">9</xref>]. In adult people, infection occurs upon contact with or ingestion of sporulated oocysts from soil, water or undercooked meat [<xref ref-type="bibr" rid="B7-Timisoara_Med-2020-9">7</xref>]. Most infected pregnant women are asymptomatic or show only mild symptoms, such as fever, headache, swollen lymph glands, general asthenia, pain and inflammation [<xref ref-type="bibr" rid="B3-Timisoara_Med-2020-9">3</xref>,<xref ref-type="bibr" rid="B10-Timisoara_Med-2020-9">10</xref>]. Often primary infections in pregnant women go unobserved and could be evoked only later by anamnesis, when signs of fetal damage appear. Intrauterine infection in early stages of pregnancy is often a cause of spontaneous abortion, and in later stages a cause of different congenital malformations such as retinochoroiditis, intracranial calcifications, hydrocephalus, hepatosplenomegaly, microcephaly or intrauterine growth restriction (IUGR) [<xref ref-type="bibr" rid="B10-Timisoara_Med-2020-9">10</xref>]. Diagnosis of acute toxoplasmosis needs serological and sometimes molecular biological testing of samples (amniotic fluid or fetal blood) [<xref ref-type="bibr" rid="B10-Timisoara_Med-2020-9">10</xref>].</p>
      <p>Cytomegalovirus is part of the <italic>Herpesviridae</italic> family, and, after a primary disease, it causes a persistent and latent infection of the host [<xref ref-type="bibr" rid="B2-Timisoara_Med-2020-9">2</xref>,<xref ref-type="bibr" rid="B5-Timisoara_Med-2020-9">5</xref>]. Usually, an IgG anti cytomegalovirus seropositive women is immune to reinfection but sometimes, if the immune system is weakened (immunosuppressive diseases (HIV, etc.) or immunosuppressive treatment (steroids, chemotherapy, etc.)), a reactivation may appear [<xref ref-type="bibr" rid="B5-Timisoara_Med-2020-9">5</xref>]. Often, a primary infection is asymptomatic or causes only a few symptoms [<xref ref-type="bibr" rid="B11-Timisoara_Med-2020-9">11</xref>].</p>
      <p>Congenital cytomegalovirus infection causes microcephaly, hepatosplenomegaly, IUGR and neuro-sensorial deficits: chorioretinitis, optic atrophy and deafness [<xref ref-type="bibr" rid="B12-Timisoara_Med-2020-9">12</xref>]. Although infected neonates are often asymptomatic, they could develop lifelong sequelae [<xref ref-type="bibr" rid="B12-Timisoara_Med-2020-9">12</xref>].</p>
      <p>Studies showed that pregnant women who are IgG seropositive to <italic>Toxoplasma gondii</italic> and cytomegalovirus are at a low risk of infecting the fetus, while seronegative ones need prophylactic hygienic measures to prevent a primary infection during pregnancy. To find out which women are seronegative, public health authorities offer in certain countries serological screening programs against these agents [<xref ref-type="bibr" rid="B1-Timisoara_Med-2020-9">1</xref>,<xref ref-type="bibr" rid="B2-Timisoara_Med-2020-9">2</xref>,<xref ref-type="bibr" rid="B3-Timisoara_Med-2020-9">3</xref>]. Faced with public health costs on the one hand and the desire to reduce the prevalence of congenital infections on the other hand, public health authorities need to evaluate the cost efficiency of screening programs. Such an analysis needs real seroprevalence data, such as the results of our study.</p>
      <p>The aim of our study was to analyze the changes in percentage of pregnant women seronegative to <italic>Toxoplasma gondii</italic> and cytomegalovirus along a period of ten years from 2008 to 2018.</p>
    </sec>
    <sec>
      <title>Materials and Methods</title>
      <sec>
        <title>Study Population</title>
        <p>We studied the changes in percentage of seronegative <italic>Toxoplasma gondii</italic> and Cytomegalovirus pregnant women along two periods: 2008&#x2013;2010 and 2015&#x2013;2018 (<xref ref-type="table" rid="Timisoara_Med-2020-9-t001">Table 1</xref>). Only pregnant women with declared medium of provenience and unequivocal results were enrolled in the study.</p>
      </sec>
      <sec>
        <title>Measurement of IgG Antibodies against Toxoplasma gondii and Cytomegalovirus</title>
        <p>Measurement of IgG anti-<italic>Toxoplasma gondii</italic> and IgG-anti-Cytomeglovirus antibodies titer was performed by immune-chemiluminescence using an Immulite One Machine (2008&#x2013;2010) and Immulite 2000 Machine (Diagnostic Products Corporation) (2015&#x2013;2018), respectively, and commercial tests (Siemens Healthcare Diagnostics Products). Patients were grouped as seropositive and seronegative, according to cut-off values recommended by the manufacturer.</p>
        <p><bold><italic>Statistical methods.</italic></bold> Astraia database and Microsoft Office Excel were used to store data. Instat GraphPad Prism 8.0.2 software was used for statistical evaluation. To assess the significance of the differences between groups, Fisher&#x2019;s exact test (proportions) was used.</p>
        <p><bold><italic>Ethical issues.</italic></bold> The present study was approved by the Institutional Board of the &#x2018;Victor Babes&#x2019; University of Medicine and Pharmacy (Timisoara, Romania) (approval no. 848/06.04.2011). The study meets the ethical guidelines, including adherence to the legal requirements of the study country.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Increase in Percentage of Seronegative IgG-Anti-Toxoplasma gondii and Cytomegalovirus Pregnant Women from 2008&#x2013;2010 to 2015&#x2013;2018</title>
        <p>Our results showed an increase in percentage of pregnant women seronegative to <italic>Toxoplasma gondii</italic> (RR = 1.077, <italic>p</italic> = 0.0031), respectively, cytomegalovirus (RR = 1.783, <italic>p</italic> &#x2264; 0.0001) (<xref ref-type="table" rid="Timisoara_Med-2020-9-t002">Table 2</xref>).</p>
      </sec>
      <sec>
        <title>Trends in Percentage of Pregnant Women Seronegative to Toxoplasma gondii and Cytomegalovirus from 2008&#x2013;2010 to 2015&#x2013;2018 Accorrding the Place of Residence</title>
        <p>In urban areas we found an increase in pregnant women seronegative to <italic>Toxoplasma gondii</italic> (RR = 1.488, <italic>p</italic> &lt; 0.0001), respectively, cytomegalovirus (RR = 1.985, <italic>p</italic> &lt; 0.0001) (<xref ref-type="table" rid="Timisoara_Med-2020-9-t002">Table 2</xref>). A similar increasing trend was also found in rural areas: <italic>Toxoplasma gondii</italic> (RR = 1.136, <italic>p</italic> &lt; 0.0322), respectively, cytomegalovirus (RR = 1.088, <italic>p</italic> &lt; 0.8265), but did not reach a significant threshold for cytomegalovirus.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Our results are part of the largest study carried out in our country. Since our previous reports presented changes in seroprevalence against TORCH agents in pregnant women along a period of ten years, our present research analyzes the trend of percentage of pregnant women seronegative to cytomegalovirus and <italic>Toxoplasma gondii</italic> in the same period (2008&#x2013;2018). Herein, we also discuss some possible explanations for this upward trend and compare our data with other data from the literature.</p>
      <p>Romania fits into the group of countries with pregnant women with low susceptibility to cytomegalovirus and medium susceptibility to <italic>Toxoplasma gondii</italic>. Usually, the higher the percentage of seropositive persons in a population, the lower the risk of a primary infection.</p>
      <p>Seroprevalence studies showed that in economically developed countries (western European Union Countries), a higher percent (30&#x2013;60%) of people are seronegative to cytomegalovirus compared to low-income countries (only 0&#x2013;4% in Africa and East Asia) [<xref ref-type="bibr" rid="B13-Timisoara_Med-2020-9">13</xref>]. Studies performed in Africa showed low rates of seronegativity to cytomegalovirus of approximatively 0% in Nigeria [<xref ref-type="bibr" rid="B14-Timisoara_Med-2020-9">14</xref>], 2.8% in Benin [<xref ref-type="bibr" rid="B15-Timisoara_Med-2020-9">15</xref>] and 4% in Egypt [<xref ref-type="bibr" rid="B16-Timisoara_Med-2020-9">16</xref>]. Interesting studies performed in the same country among socio-economically different groups of people showed that people with higher education and income had a higher seronegative rate compared to people with lower socio-economic status [<xref ref-type="bibr" rid="B17-Timisoara_Med-2020-9">17</xref>]. </p>
      <p>Analyzing the course of seronegativity to CMV over the years in Japan showed that the prevalence of seronegative people increased over time, from 30.1% in 2003 to 34.8% in 2012 [<xref ref-type="bibr" rid="B18-Timisoara_Med-2020-9">18</xref>]. Scientists from Japan speculate that the decline in birth rate reduces the chance of child-to-child contact and could explain the increase in prevalence of seronegative people. Another cause could be better hygiene counseling of pregnant women by public authorities and spread of information about the consequences of congenital CMV infection [<xref ref-type="bibr" rid="B18-Timisoara_Med-2020-9">18</xref>].</p>
      <p>Our study shows that the percentage of seronegative pregnant women increased overall in our region, from 5.27% to 9.05%. Such a trend was found in urban areas, with an increase from 5.5% to 10.92%. A similar ascending trend from 4.66% to 5.07% was found in rural areas, too but it did not reach a significant threshold. We have no explanation as to why this trend was not significant among pregnant women from rural areas. Maybe the smaller number of women in the rural group did not ensure a sufficient number of patients producing significant results. Another explanation could be that the hygienic improvement or the decline in birth rates was not significant in rural areas in this interval. </p>
      <p><italic>Toxoplasma gondii</italic> is a worldwide spread parasite. The percentage of general population who are seronegative to <italic>Toxoplasma gondii</italic> varies between 70 and 75% around the globe [<xref ref-type="bibr" rid="B7-Timisoara_Med-2020-9">7</xref>], while it drops to 28% in Latin America [<xref ref-type="bibr" rid="B19-Timisoara_Med-2020-9">19</xref>]. In other European countries, the percentage of seronegative childbearing women varies from 81% in Great Britain [<xref ref-type="bibr" rid="B20-Timisoara_Med-2020-9">20</xref>] to 56% in France [<xref ref-type="bibr" rid="B21-Timisoara_Med-2020-9">21</xref>].</p>
      <p>Our data showed that the percentage of seronegative pregnant women increased overall from 56.21% (2008&#x2013;2010) to 61.19% (2015&#x2013;2018). The same trend was found in both urban (from 43.78% to 65.15%) and rural (from 47.78% to 53.78%) areas.</p>
      <p>An increase in the percentage of seronegative <italic>Toxoplasma gondii</italic> persons was found in other countries, too. For example, in the United States of America, this percentage increased from 77&#x2013;86% (1988&#x2013;1994) to 91% (1999&#x2013;2004) and 94% (2009&#x2013;2010). The increase in percentage of seronegative pregnant women was steeper in urban areas than in rural areas, maybe because of better improvement in hygienic conditions in urban areas. Similar to cytomegalovirus infection, low socio-economic status, contact with animals and uncooked meat are associated with a higher contamination rate and a lower seronegativity rate [<xref ref-type="bibr" rid="B22-Timisoara_Med-2020-9">22</xref>,<xref ref-type="bibr" rid="B23-Timisoara_Med-2020-9">23</xref>].</p>
      <p>Such an increasing trend in the percentage of seronegative pregnant women leads to more attention from public authorities and the development of more extensive serological screening programs. More information strategies about preventive measures and about the risk of congenital infection after primary contact with these agents must be delivered to the population. </p>
      <p>There are certain differences between the urban and rural population in terms of hygiene. For instance, studies showed that some infectious agents are present in backyard pigs in Romania and the consumption of pork meat at home may increase the risk of human infection [<xref ref-type="bibr" rid="B24-Timisoara_Med-2020-9">24</xref>]. Water supply and hygienic features are different [<xref ref-type="bibr" rid="B25-Timisoara_Med-2020-9">25</xref>]. This may explain some of the differences between rural and urban areas.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Our study showed that the percentage of women seronegative to <italic>Toxoplasma gondii</italic> and cytomegalovirus antibodies increases along a period of ten years, from 2008&#x2013;2010 to 2015&#x2013;2018, in both urban and rural areas. Probably, the main cause of this trend is represented by the improvement in hygienic condition and food quality control. These results argue for continuing the TORCH screening of pregnant women.</p>
    </sec>
  </body>
  <back>
    <notes>
      <title>Author Contributions</title>
      <p>D.-B.N., F.G., I.-M.C., and M.L.C. were involved in the conception of the study and data interpretation. C.O. and D.M. contributed to data collection and performed the statistical analysis. I.-M.C. performed serological testing. D.-B.N., F.G., I.-M.C., and M.L.C. wrote the manuscript. I.-M.C., C.O. and D.M. revised the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.</p>
    </notes>
	 <notes>
        <title>Funding</title>
      <p>This research received no external funding.</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-Timisoara_Med-2020-9">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navolan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ciohat</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Tigla</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Vasies</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dumitrascu</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Risk Assessment for TORCH complex infection agents during pregnancy: Preliminary study</article-title>
          <source>TMJ</source>
          <year>2012</year>
          <volume>62</volume>
          <fpage>15</fpage>
          <lpage>19</lpage>
        </element-citation>
      </ref>
      <ref id="B2-Timisoara_Med-2020-9">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorun</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Motoi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Malita</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Navolan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nemescu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Olariu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Craina</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vilibic-Cavlek</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ciohat</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Boda</surname>
              <given-names>D.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytomegalovirus seroprevalence in pregnant women in the western region of Romania: A large-scale study</article-title>
          <source>ETM</source>
          <year>2020</year>
          <volume>20</volume>
          <fpage>2439</fpage>
          <lpage>2443</lpage>
          <pub-id pub-id-type="doi">10.3892/etm.2020.8945</pub-id>
          <pub-id pub-id-type="pmid">32765730</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-Timisoara_Med-2020-9">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motoi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Navolan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Malita</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ciohat</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Nemescu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Manciuc</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gorun</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vilibic-Cavlek</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Boda</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Craina</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A decreasing trend in <italic>Toxoplasma gondii</italic> seroprevalence among pregnant women in Romania&#x2014;Results of a large scale study</article-title>
          <source>ETM</source>
          <year>2020</year>
          <volume>20</volume>
          <fpage>3536</fpage>
          <lpage>3540</lpage>
        </element-citation>
      </ref>
      <ref id="B4-Timisoara_Med-2020-9">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pomares</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Devillard</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Olariu</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Press</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Ramirez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Talucod</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Estran</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Dubey</surname>
              <given-names>J.P.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic Characterization of <italic>Toxoplasma gondii</italic> DNA Samples Isolated From Humans Living in North America: An Unexpected High Prevalence of Atypical Genotypes</article-title>
          <source>J. Infect. Dis.</source>
          <year>2018</year>
          <volume>218</volume>
          <fpage>1783</fpage>
          <lpage>1791</lpage>
          <pub-id pub-id-type="doi">10.1093/infdis/jiy375</pub-id>
          <pub-id pub-id-type="pmid">29982713</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-Timisoara_Med-2020-9">
        <label>5.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kasper</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Longo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Loscalzo</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Harrison&#x2019;s Principles of Internal Medicine</source>
          <edition>20th ed.</edition>
          <publisher-name>Publisher McGraw-Hill Education</publisher-name>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <year>2018</year>
          <fpage>1361</fpage>
          <lpage>1365</lpage>
        </element-citation>
      </ref>
      <ref id="B6-Timisoara_Med-2020-9">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iemmi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Vismarra</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mangia</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zanin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Genchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lanfranchi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Formenti</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title><italic>Toxoplasma gondii</italic> in the Eurasian kestrel (<italic>Falco tinnunculus</italic>) in northern Italy</article-title>
          <source>Parasites Vectors</source>
          <year>2020</year>
          <volume>13</volume>
          <fpage>262</fpage>
          <pub-id pub-id-type="doi">10.1186/s13071-020-04134-x</pub-id>
          <pub-id pub-id-type="pmid">32429990</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-Timisoara_Med-2020-9">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>English</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Striepen</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>The cat is out of the bag: How parasites know their hosts</article-title>
          <source>PLoS Biol.</source>
          <year>2019</year>
          <volume>17</volume>
          <elocation-id>e3000446</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.3000446</pub-id>
          <pub-id pub-id-type="pmid">31487278</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-Timisoara_Med-2020-9">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duong</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Appiah-Kwarteng</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Takashima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Aye</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Nagayasu</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A novel luciferase-linked antibody capture assay (LACA) for the diagnosis of <italic>Toxoplasma gondii</italic> infection in chickens</article-title>
          <source>Parasitol. Int.</source>
          <year>2020</year>
          <volume>77</volume>
          <fpage>102125</fpage>
          <pub-id pub-id-type="doi">10.1016/j.parint.2020.102125</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-Timisoara_Med-2020-9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foroutan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fakhri</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Riahi</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Ebrahimpour</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Namroodi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Taghipour</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Spotin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gamble</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Rostami</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The global seroprevalence of <italic>Toxoplasma gondii</italic> in pigs: A systematic review and meta-analysis</article-title>
          <source>Vet. Parasitol.</source>
          <year>2019</year>
          <volume>269</volume>
          <fpage>42</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1016/j.vetpar.2019.04.012</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-Timisoara_Med-2020-9">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Congenital toxoplasmosis: An overview of the neurological and ocular manifestations</article-title>
          <source>Parasitol. Int.</source>
          <year>2018</year>
          <volume>67</volume>
          <fpage>715</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="doi">10.1016/j.parint.2018.07.004</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-Timisoara_Med-2020-9">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>P&#xE9;rillaud-Dubois</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bouthry</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jadoui</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Leng</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Roque-Afonso</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Vauloup-Fellous</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study</article-title>
          <source>J. Clin. Virol.</source>
          <year>2020</year>
          <volume>9</volume>
          <fpage>104641</fpage>
          <pub-id pub-id-type="doi">10.1016/j.jcv.2020.104641</pub-id>
        </element-citation>
      </ref>
      <ref id="B12-Timisoara_Med-2020-9">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kagan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hamprecht</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Cytomegalovirus infection in pregnancy</article-title>
          <source>Arch. Gynecol. Obstet.</source>
          <year>2017</year>
          <volume>296</volume>
          <fpage>15</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1007/s00404-017-4380-2</pub-id>
        </element-citation>
      </ref>
      <ref id="B13-Timisoara_Med-2020-9">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al Mana</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yassine</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Younes</surname>
              <given-names>N.N.</given-names>
            </name>
            <name>
              <surname>Al-Mohannadi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Al-Sadeq</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Alhababi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nasser</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Nasrallah</surname>
              <given-names>G.K.</given-names>
            </name>
          </person-group>
          <article-title>The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review</article-title>
          <source>Pathogens</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>213</fpage>
          <pub-id pub-id-type="doi">10.3390/pathogens8040213</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-Timisoara_Med-2020-9">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>J.O.</given-names>
            </name>
            <name>
              <surname>Fagbami</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Omilabu</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Cytomegalovirus antibodies in Nigeria</article-title>
          <source>Trans. R. Soc. Trop. Med. Hyg.</source>
          <year>1989</year>
          <volume>83</volume>
          <fpage>260</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(89)90671-8</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-Timisoara_Med-2020-9">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodier</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Berthonneau</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bourgoin</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Giraudeau</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Agius</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Burucoa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hekpazo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jacquemin</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Seroprevalences of Toxoplasma, malaria, rubella, cytomegalovirus, HIV and treponemal infections among pregnant women in Cotonou, Republic of Benin</article-title>
          <source>Acta Trop.</source>
          <year>1995</year>
          <volume>59</volume>
          <fpage>271</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="doi">10.1016/0001-706X(95)00087-U</pub-id>
        </element-citation>
      </ref>
      <ref id="B16-Timisoara_Med-2020-9">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Nawawy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Soliman</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>El Azzouni</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Amer</surname>
              <given-names>E.-S.</given-names>
            </name>
            <name>
              <surname>Karim</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Demian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>El-Sayed</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area</article-title>
          <source>J. Trop. Pediatr.</source>
          <year>1996</year>
          <volume>42</volume>
          <fpage>154</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1093/tropej/42.3.154</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-Timisoara_Med-2020-9">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Odland</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Strand</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Nordb&#xF8;</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Forsmo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Austgulen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Iversen</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Changing patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian Mother and Child Cohort Study and two cohorts from S&#xF8;r-Tr&#xF8;ndelag County: A cross-sectional study</article-title>
          <source>BMJ Open</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>e003066</fpage>
          <pub-id pub-id-type="doi">10.1136/bmjopen-2013-003066</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-Timisoara_Med-2020-9">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jwa</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamanobe</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sago</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kozuka</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Changes in cytomegalovirus seroprevalence in pregnant Japanese women&#x2014;A 10-year single center study</article-title>
          <source>J. Clin. Virol.</source>
          <year>2014</year>
          <volume>59</volume>
          <fpage>192</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcv.2013.12.013</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-Timisoara_Med-2020-9">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rorman</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Zamir</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Rilkis</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Ben-David</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Congenital toxoplasmosis--prenatal aspects of <italic>Toxoplasma gondii</italic> infection</article-title>
          <source>Reprod. Toxicol.</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>458</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1016/j.reprotox.2005.10.006</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-Timisoara_Med-2020-9">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nash</surname>
              <given-names>J.Q.</given-names>
            </name>
            <name>
              <surname>Chissel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Warburton</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Verlander</surname>
              <given-names>N.Q.</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom</article-title>
          <source>Epidemiol. Infect.</source>
          <year>2005</year>
          <volume>133</volume>
          <fpage>475</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="doi">10.1017/S0950268804003620</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-Timisoara_Med-2020-9">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Goulet</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Le Strat</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Desenclos</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Toxoplasmosis among pregnant women in France: Risk factors and change of prevalence between 1995 and 2003</article-title>
          <source>Rev. Epidemiol. Sante Publique</source>
          <year>2009</year>
          <volume>57</volume>
          <fpage>241</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1016/j.respe.2009.03.006</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-Timisoara_Med-2020-9">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belluco</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mancin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Conficoni</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Simonato</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pietrobelli</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ricci</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Investigating the Determinants of <italic>Toxoplasma gondii</italic> Prevalence in Meat: A Systematic Review and Meta-Regression</article-title>
          <source>PLoS ONE</source>
          <year>2016</year>
          <volume>11</volume>
          <elocation-id>e0153856</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0153856</pub-id>
          <pub-id pub-id-type="pmid">27082633</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-Timisoara_Med-2020-9">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mareze</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Benitez</surname>
              <given-names>A.D.N.</given-names>
            </name>
            <name>
              <surname>Brand&#xE3;o</surname>
              <given-names>A.P.D.</given-names>
            </name>
            <name>
              <surname>Pinto-Ferreira</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>F.D.C.</given-names>
            </name>
            <name>
              <surname>Caldart</surname>
              <given-names>E.T.</given-names>
            </name>
            <name>
              <surname>Biondo</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Freire</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Mitsuka-Bregan&#xF3;</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Socioeconomic vulnerability associated to <italic>Toxoplasma gondii</italic> exposure in southern Brazil</article-title>
          <source>PLoS ONE</source>
          <year>2019</year>
          <volume>14</volume>
          <elocation-id>e0212375</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0212375</pub-id>
          <pub-id pub-id-type="pmid">30763391</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-Timisoara_Med-2020-9">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pa&#x15F;tiu</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Cozma-Petru&#x21B;</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mercier</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Balea</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Galal</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mircean</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Pusta</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Bogdan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gy&#xF6;rke</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and genetic characterization of <italic>Toxoplasma gondii</italic> in naturally infected backyard pigs intended for familial consumption in Romania</article-title>
          <source>Parasites Vectors</source>
          <year>2019</year>
          <volume>12</volume>
          <fpage>586</fpage>
          <pub-id pub-id-type="doi">10.1186/s13071-019-3842-8</pub-id>
          <pub-id pub-id-type="pmid">31842955</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-Timisoara_Med-2020-9">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frone</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Frone</surname>
              <given-names>D.F.</given-names>
            </name>
          </person-group>
          <article-title>Promoting access to water supply and sanitation: Issues and challenges in Romania</article-title>
          <source>Econ. Eng. Agric. Rural Dev.</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>165</fpage>
          <lpage>170</lpage>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Tables</title>
      <table-wrap id="Timisoara_Med-2020-9-t001" position="float">
        <object-id pub-id-type="pii">Timisoara_Med-2020-9-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Pregnant women tested against IgG anti-<italic>Toxoplasma gondii</italic> and Cytomegalovirus according the medium of provenience.</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin"> </th>
              <th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin">2008&#x2013;2010</th>
              <th colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin">2015&#x2013;2018</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="2" align="left" valign="middle">
                <italic>Toxoplasma gondii</italic>
              </td>
              <td colspan="2" align="left" valign="middle">1457</td>
              <td colspan="2" align="left" valign="middle">5432</td>
            </tr>
            <tr>
              <td align="left" valign="middle">U = 1051</td>
              <td align="left" valign="middle">R = 406</td>
              <td align="left" valign="middle">U = 3541</td>
              <td align="left" valign="middle">R = 1891</td>
            </tr>
            <tr>
              <td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin">Cytomegalovirus</td>
              <td colspan="2" align="left" valign="middle">1461</td>
              <td colspan="2" align="left" valign="middle">5500</td>
            </tr>
            <tr>
              <td align="left" valign="middle" style="border-bottom:solid thin">U = 1054</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">R = 407</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">U = 3570</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">R = 1930</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="Timisoara_Med-2020-9-t002" position="float">
        <object-id pub-id-type="pii">Timisoara_Med-2020-9-t002_Table 2</object-id>
        <label>Table 2</label>
        <caption>
          <p>Seronegative pregnant women to <italic>Toxoplasma gondii</italic> and cytomegalovirus according to place of residence along two periods: 2008&#x2013;2010 and 2015&#x2013;2018.</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin"> </th>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin">2008&#x2013;2010</th>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin">2015&#x2013;2018</th>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin">RR</th>
              <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><italic>p</italic> Value</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="middle">
                <bold>All</bold>
              </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <italic>Toxoplasma gondii</italic>
              </td>
              <td align="left" valign="middle">819/1457 (56.21%)</td>
              <td align="left" valign="middle">3324/5432 (61.19%)</td>
              <td align="left" valign="middle">1.077</td>
              <td align="left" valign="middle">0.0031</td>
            </tr>
            <tr>
              <td align="left" valign="middle">CMV</td>
              <td align="left" valign="middle">77/1461 (5.27%)</td>
              <td align="left" valign="middle">498/5500 (9.05%)</td>
              <td align="left" valign="middle">1.783</td>
              <td align="left" valign="middle">&lt;0.0001</td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <bold>Urban areas</bold>
              </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <italic>Toxoplasma gondii</italic>
              </td>
              <td align="left" valign="middle">638/1457 (43.78%)</td>
              <td align="left" valign="middle">2307/3541 (65.15%)</td>
              <td align="left" valign="middle">1.488</td>
              <td align="left" valign="middle">&lt;0.0001</td>
            </tr>
            <tr>
              <td align="left" valign="middle">CMV</td>
              <td align="left" valign="middle">58/1054 (5.50%)</td>
              <td align="left" valign="middle">390/3570 (10.92%)</td>
              <td align="left" valign="middle">1.985</td>
              <td align="left" valign="middle">&lt;0.0001</td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <bold>Rural areas</bold>
              </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="left" valign="middle">
                <italic>Toxoplasma gondii</italic>
              </td>
              <td align="left" valign="middle">194/406 (47.78%)</td>
              <td align="left" valign="middle">1017/1891 (53.78%)</td>
              <td align="left" valign="middle">1.136</td>
              <td align="left" valign="middle">=0.0322</td>
            </tr>
            <tr>
              <td align="left" valign="middle" style="border-bottom:solid thin">CMV</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">19/407 (4.66%)</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">98/1930 (5.07%)</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">1.088</td>
              <td align="left" valign="middle" style="border-bottom:solid thin">0.8265</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </back>
</article>
